EUVIMEDEUVIMED entdecken
Open Access

Palmoplantar Psoriasis: Epidemiological and Clinical Features and Impact on Quality of Life

Dorsaf Elinkichari, Faten Rabhi, Kahena Jaber, Raouf Dhaoui

Dermatology Practical & Conceptual · 31.07.2024 · 14 (3) · e2024191

DOI: 10.5826/dpc.1403a191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology Practical & Conceptual, online erschienen am 31.07.2024. Verfasst von Dorsaf Elinkichari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Military Hospital of Tunis, Tunisia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Palmoplantar psoriasis is a rare variant of psoriasis. Its impact on quality of life have been poorly investigated.

Objectives

Our aim was to investigate the prevalence of localized palmoplantar psoriasis (PPP), to assess its severity using the modified-Palmoplantar Pustular Psoriasis Area and Severity Index (m-PPPASI), and to evaluate the correlation with the Dermatology Life Quality Index (DLQI).

Methods

We conducted a descriptive study with prospective data-collection from January to June 2021. We enrolled 223 patients with psoriasis. We excluded patients without palmar/plantar involvement, and those with a body surface area (BSA) greater than or equal to 10%.

Results

We included 33 patients with PPP. This corresponded to a 14.8% prevalence among all psoriasis phenotypes. The mean age was 45 years. The male to female ratio was 2.3. Pruritus was present in 27 cases. The mean m-PPPASI was 11.77. The mean DLQI was 8.33. A significant correlation was found between DLQI and m-PPPASI: Mean DLQI scores for patients with m-PPPASI less than or equal to 10 and m-PPPASI greater than 10 were 5.6 and 11.3, respectively (p=0.002). Only 11.8% of patients with m-PPPASI less than or equal to 10 had a DLQI greater than 10, whereas 50% of those with m-PPPASI greater than 10 had a DLQI greater than 10 (p=0.026).

Conclusions

Based on the present work, we confirm that, although affecting a reduced BSA, PPP is a severe form of psoriasis. We consider the m-PPPASI to be a reliable tool which can be used to assess the severity of PPP.

Autor:innen und Institutionen

  • Dermatology Department, Military Hospital of Tunis, Tunisia.
  • Faculty of Medicine of Tunis, University of Tunis EL MANAR, Tunisia.

Zitieren

APA

Elinkichari, D., Rabhi, F., Jaber, K., & Dhaoui, R. (2024). Palmoplantar Psoriasis: Epidemiological and Clinical Features and Impact on Quality of Life. Dermatology Practical & Conceptual, 14(3), e2024191. https://doi.org/10.5826/dpc.1403a191

Vancouver

Elinkichari D, Rabhi F, Jaber K, Dhaoui R. Palmoplantar Psoriasis: Epidemiological and Clinical Features and Impact on Quality of Life. Dermatology Practical & Conceptual. 2024;14(3):e2024191. doi:10.5826/dpc.1403a191

BibTeX
@article{Elinkichari2024,
  author = {Elinkichari, Dorsaf and Rabhi, Faten and Jaber, Kahena and Dhaoui, Raouf},
  title = {Palmoplantar Psoriasis: Epidemiological and Clinical Features and Impact on Quality of Life},
  journal = {Dermatology Practical & Conceptual},
  year = {2024},
  volume = {14},
  number = {3},
  pages = {e2024191},
  doi = {10.5826/dpc.1403a191}
}
Kostenlos starten →